Vanda's petition for rehearing on patent invalidation denied by Federal Circuit

Vanda Pharmaceuticals Inc.

Federal Circuit denied Vanda's rehearing petition on August 16, 2023, affirming invalidity of four patents.
Patents RE46,604; 9,730,910; 10,149,829; and 10,376,487 held invalid by District Court decision.
Federal Circuit originally affirmed invalidation on May 10, 2023; Vanda sought rehearing on June 9, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.